LEADER 04412nam 22006494a 450 001 9910220109903321 005 20200520144314.0 010 $a1-282-28298-0 010 $a9780833033859 010 $a9786612282980 010 $a0-8330-3385-9 035 $a(CKB)111087028056452 035 $a(EBL)202773 035 $a(OCoLC)475918021 035 $a(SSID)ssj0000241934 035 $a(PQKBManifestationID)11218698 035 $a(PQKBTitleCode)TC0000241934 035 $a(PQKBWorkID)10299856 035 $a(PQKB)11539796 035 $a(Au-PeEL)EBL202773 035 $a(CaPaEBR)ebr10056165 035 $a(MiAaPQ)EBC202773 035 $a(EXLCZ)99111087028056452 100 $a20020620d2002 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aSchool-based drug prevention $ewhat kind of drug use does it prevent? /$fJonathan P. Caulkins ... [et al.] 205 $a1st ed. 210 $aSanta Monica, CA $cRand$d2002 215 $a1 online resource (199 p.) 300 $a"MR-1459." 311 $a0-8330-3082-5 320 $aIncludes bibliographical references (p. 165-174). 327 $aPREFACE; CONTENTS; FIGURES; TABLES; SUMMARY; ACKNOWLEDGMENTS; Chapter One INTRODUCTION; ARE PREVENTION'S EFFECTS LARGE ENOUGH TO BE WORTH THE EFFORT?; BACKGROUND AND GOALS OF THIS STUDY; OUR APPROACH: ITS STRENGTHS AND WEAKNESSES; ORGANIZATION OF THIS REPORT; Chapter Two SOCIAL BENEFIT AND COST RESULTS; HOW WE ESTIMATE PREVENTION'S SOCIAL BENEFITS; SOCIAL BENEFIT RESULTS; SCHOOL-BASED PREVENTION'S SOCIAL COSTS; SENSITIVITY OF FINDINGS TO VARIATIONS IN ASSUMPTIONS; OTHER RESULTS OF INTEREST; CONCLUSIONS AND DISCUSSION; Chapter Three LIFETIME DRUG CONSUMPTION WITHOUT PREVENTION 327 $aHOW MUCH DO USERS CONSUME OVER THEIR LIVES?WHAT IS THE PROBABILITY THAT SOMEONE WILL BECOME A USER?; HOW SHOULD PRESENT AND FUTURE QUANTITIES BE COMPARED? (THE DISCOUNT FACTOR); Chapter Four SCHOOL-BASED DRUG PREVENTION'S EFFECTIVENESS AT THE END OF THE PROGRAM; SELECTION OF PROGRAMS UPON WHICH COMPOSITE ESTIMATES ARE BASED; MEASURES OF EFFECTIVENESS; INDIVIDUAL PROGRAM EFFECTS; AGGREGATE PROGRAM EFFECTS; Chapter Five SCHOOL-BASED PREVENTION'S EFFECTIVENESS AT REDUCING LIFETIME DRUG USE; MEASURING DECAY OF SHORT-TERM EFFECT; TAKING ACCOUNT OF LENGTH OF INITIATION DELAY 327 $aTRANSLATING EFFECTIVENESS PREDICTORS TO RESULTSChapter Six ADJUSTMENTS TO PREVENTION'S EFFECTIVENESS; CAUSATION VERSUS CORRELATION QUALIFIER; SCALE-UP QUALIFIER; SOCIAL MULTIPLIER; MARKET MULTIPLIER; Chapter Seven SOCIAL COSTS OF DRUG CONSUMPTION; ESTIMATING THE SOCIAL COST OF ALCOHOL USE; ESTIMATING THE SOCIAL COST OF TOBACCO USE; ESTIMATING THE SOCIAL COST OF COCAINE USE AND USE OF ILLICIT DRUGS IN GENERAL; ESTIMATING THE SOCIAL COST OF MARIJUANA USE; SUMMARY; Appendix A LOW, MEDIUM, AND HIGH ESTIMATES FOR THE TEN FACTORS IN THE PREVENTION MODEL 327 $aAppendix B RECODING CONSUMPTION VALUES FROM THE NATIONAL HOUSEHOLD SURVEY ON DRUG ABUSEAppendix C PROGRAM DESCRIPTIONS; Appendix D AGGREGATING PROGRAM EFFECTIVENESS DATA; Appendix E PROGRAM EFFECTIVENESS DECAY; Appendix F EFFECTS ON LIFETIME CONSUMPTION; BIBLIOGRAPHY 330 $aSchool-based drug prevention, popular with the public and politicians alike, is now a nearly universal experience for American youth. Analysis has shown that the best programs can reduce use of a wide range of substances. But questions remain regarding how to think about and, hence, fund, these programs. Should they be viewed principally as weapons in the war against illicit drugs, or, at the other extreme, do prevention programs benefit students and society most by reducing use of alcohol and tobacco? The authors address these questions by comparing for the first time the social benefits of 606 $aStudents$xDrug use$zUnited States 606 $aYouth$xDrug use$zUnited States 606 $aDrug abuse$zUnited States$xPrevention 615 0$aStudents$xDrug use 615 0$aYouth$xDrug use 615 0$aDrug abuse$xPrevention. 676 $a362.29/17/0973 701 $aCaulkins$b Jonathan P$g(Jonathan Paul),$f1965-$0889404 712 02$aRand Corporation. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910220109903321 996 $aSchool-based drug prevention$92023219 997 $aUNINA